Use of intravenous acetaminophen (paracetamol) in a pediatric patient at the end of life: case report

Use of intravenous acetaminophen (paracetamol) in a pediatric patient at the end of life: case report

Marks AD; Keefer P; Saul D'Anna

Journal Of Palliative Medicine

2013

Child; Female; Humans; Pain; Terminal Care; Analgesics; Fatal Outcome; Ovarian Neoplasms; Injections; Intravenous; Acetaminophen; Non-Narcotic; Sertoli-Leydig Cell Tumor

BACKGROUND: For the better part of 100 years, acetaminophen (or paracetamol as it is known outside of the United States) has been a common first-line analgesic in pediatrics and is typically well tolerated with minimal side effects. Its use as an anti-pyretic is also well-documented and thus it is used broadly for symptom control in the general pediatric population. DISCUSSION: In pediatric palliative care, acetaminophen is also used as an adjuvant to opioid therapy for pain as well as an anti-pyretic. For many pediatric patients near end-of-life, however, the ability to tolerate oral intake is diminished and rectal suppository administration can be distressing or contraindicated as in the setting of neutropenia, thus limiting use of acetaminophen by its usual routes. In Europe and Australia, an intravenous formulation of acetaminophen has been used for many years and has only recently become available in the United States. CONCLUSION: Here, we describe a case using intravenous acetaminophen in a pediatric patient at the end of life.

2013-12

Article information provided for research and reference use only. PedPalASCNET does not hold any rights over the resource listed here. All rights are retained by the journal listed under publisher and/or the creator(s).

Journal Article

Backlog